These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26404080)

  • 1. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.
    León IE; Cadavid-Vargas JF; Tiscornia I; Porro V; Castelli S; Katkar P; Desideri A; Bollati-Fogolin M; Etcheverry SB
    J Biol Inorg Chem; 2015 Oct; 20(7):1175-91. PubMed ID: 26404080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
    Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
    J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
    León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
    J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
    Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
    Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
    León IE; Díez P; Etcheverry SB; Fuentes M
    Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
    León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
    J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
    Roy S; Chakraborty T
    Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic effects of VOflavonoid complexes on A549 cell line.
    Naso LG; Martínez VR; Ferrer EG; Williams PAM
    J Trace Elem Med Biol; 2021 Mar; 64():126690. PubMed ID: 33260045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
    León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
    Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
    Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
    Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
    Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
    Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin.
    Naso L; Martínez VR; Lezama L; Salado C; Valcarcel M; Ferrer EG; Williams PAM
    Bioorg Med Chem; 2016 Sep; 24(18):4108-4119. PubMed ID: 27374881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
    Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
    Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the cytotoxic, antimetastatic and albumin binding properties of the oxidovanadium(IV) chrysin complex. Structural elucidation by computational methodologies.
    Naso LG; Martínez Medina JJ; Okulik NB; Ferrer EG; Williams PAM
    Chem Biol Interact; 2022 Jan; 351():109750. PubMed ID: 34813780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
    Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
    Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
    Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
    Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity evaluation of novel chrysin-organogermanium(IV) complex in MCF-7 cells.
    Yang F; Jin H; Pi J; Jiang JH; Liu L; Bai HH; Yang PH; Cai JY
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5544-51. PubMed ID: 24007917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
    Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
    J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Adenocarcinoma Cell Lines.
    Kowalski S; Wyrzykowski D; Hac S; Rychlowski M; Radomski MW; Inkielewicz-Stepniak I
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.